Cargando…
An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines
BACKGROUND: The Autotransporter pathway, ubiquitous in Gram-negative bacteria, allows the efficient secretion of large passenger proteins via a relatively simple mechanism. Capitalizing on its crystal structure, we have engineered the Escherichia coli autotransporter Hemoglobin protease (Hbp) into a...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252983/ https://www.ncbi.nlm.nih.gov/pubmed/25421093 http://dx.doi.org/10.1186/s12934-014-0162-8 |
_version_ | 1782347210793418752 |
---|---|
author | Jong, Wouter SP Daleke-Schermerhorn, Maria H Vikström, David ten Hagen-Jongman, Corinne M de Punder, Karin van der Wel, Nicole N van de Sandt, Carolien E Rimmelzwaan, Guus F Follmann, Frank Agger, Else Marie Andersen, Peter de Gier, Jan-Willem Luirink, Joen |
author_facet | Jong, Wouter SP Daleke-Schermerhorn, Maria H Vikström, David ten Hagen-Jongman, Corinne M de Punder, Karin van der Wel, Nicole N van de Sandt, Carolien E Rimmelzwaan, Guus F Follmann, Frank Agger, Else Marie Andersen, Peter de Gier, Jan-Willem Luirink, Joen |
author_sort | Jong, Wouter SP |
collection | PubMed |
description | BACKGROUND: The Autotransporter pathway, ubiquitous in Gram-negative bacteria, allows the efficient secretion of large passenger proteins via a relatively simple mechanism. Capitalizing on its crystal structure, we have engineered the Escherichia coli autotransporter Hemoglobin protease (Hbp) into a versatile platform for secretion and surface display of multiple heterologous proteins in one carrier molecule. RESULTS: As proof-of-concept, we demonstrate efficient secretion and high-density display of the sizeable Mycobacterium tuberculosis antigens ESAT6, Ag85B and Rv2660c in E. coli simultaneously. Furthermore, we show stable multivalent display of these antigens in an attenuated Salmonella Typhimurium strain upon chromosomal integration. To emphasize the versatility of the Hbp platform, we also demonstrate efficient expression of multiple sizeable antigenic fragments from Chlamydia trachomatis and the influenza A virus at the Salmonella cell surface. CONCLUSIONS: The successful efficient cell surface display of multiple antigens from various pathogenic organisms highlights the potential of Hbp as a universal platform for the development of multivalent recombinant bacterial vector vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-014-0162-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4252983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42529832014-12-04 An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines Jong, Wouter SP Daleke-Schermerhorn, Maria H Vikström, David ten Hagen-Jongman, Corinne M de Punder, Karin van der Wel, Nicole N van de Sandt, Carolien E Rimmelzwaan, Guus F Follmann, Frank Agger, Else Marie Andersen, Peter de Gier, Jan-Willem Luirink, Joen Microb Cell Fact Research BACKGROUND: The Autotransporter pathway, ubiquitous in Gram-negative bacteria, allows the efficient secretion of large passenger proteins via a relatively simple mechanism. Capitalizing on its crystal structure, we have engineered the Escherichia coli autotransporter Hemoglobin protease (Hbp) into a versatile platform for secretion and surface display of multiple heterologous proteins in one carrier molecule. RESULTS: As proof-of-concept, we demonstrate efficient secretion and high-density display of the sizeable Mycobacterium tuberculosis antigens ESAT6, Ag85B and Rv2660c in E. coli simultaneously. Furthermore, we show stable multivalent display of these antigens in an attenuated Salmonella Typhimurium strain upon chromosomal integration. To emphasize the versatility of the Hbp platform, we also demonstrate efficient expression of multiple sizeable antigenic fragments from Chlamydia trachomatis and the influenza A virus at the Salmonella cell surface. CONCLUSIONS: The successful efficient cell surface display of multiple antigens from various pathogenic organisms highlights the potential of Hbp as a universal platform for the development of multivalent recombinant bacterial vector vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-014-0162-8) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-25 /pmc/articles/PMC4252983/ /pubmed/25421093 http://dx.doi.org/10.1186/s12934-014-0162-8 Text en © Jong et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Jong, Wouter SP Daleke-Schermerhorn, Maria H Vikström, David ten Hagen-Jongman, Corinne M de Punder, Karin van der Wel, Nicole N van de Sandt, Carolien E Rimmelzwaan, Guus F Follmann, Frank Agger, Else Marie Andersen, Peter de Gier, Jan-Willem Luirink, Joen An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines |
title | An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines |
title_full | An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines |
title_fullStr | An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines |
title_full_unstemmed | An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines |
title_short | An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines |
title_sort | autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252983/ https://www.ncbi.nlm.nih.gov/pubmed/25421093 http://dx.doi.org/10.1186/s12934-014-0162-8 |
work_keys_str_mv | AT jongwoutersp anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT dalekeschermerhornmariah anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT vikstromdavid anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT tenhagenjongmancorinnem anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT depunderkarin anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT vanderwelnicolen anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT vandesandtcaroliene anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT rimmelzwaanguusf anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT follmannfrank anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT aggerelsemarie anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT andersenpeter anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT degierjanwillem anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT luirinkjoen anautotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT jongwoutersp autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT dalekeschermerhornmariah autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT vikstromdavid autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT tenhagenjongmancorinnem autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT depunderkarin autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT vanderwelnicolen autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT vandesandtcaroliene autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT rimmelzwaanguusf autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT follmannfrank autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT aggerelsemarie autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT andersenpeter autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT degierjanwillem autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines AT luirinkjoen autotransporterdisplayplatformforthedevelopmentofmultivalentrecombinantbacterialvectorvaccines |